BECILICA
Samsung Bioepis Co., Ltd.
Mark For: BECILICA® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88519013 |
| Registration Number | 6045728 |
| Mark Literal Elements | BECILICA |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2020-01-14 |
| Basis | 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | Yes |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Stephen R. Barrese, Esq. |
| Attorney Docket Number | 587-1018 |
| Law Office Assigned | L70 |
| Employee Name | COLLOPY, DIANE PATRICI |
Timeline
| 2019-07-16 | Trademark Registered |
| 2019-07-17 | Application Filed |
| 2019-10-10 | Location: TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED |
| 2019-10-10 | Status: Live/Pending |
| 2019-12-20 | Transaction Date |
| 2020-01-14 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-02-18 | Published |
| 2020-02-18 | Status: Application has been published for opposition. The opposition period begins on the date of publication. |
| 2020-05-05 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  Samsung Bioepis Co., Ltd. |
| Address | 107, Cheomdan-daero, Yeonsu-gu, Incheon KOREA, REPUBLIC OF 21987 |
| Legal Entity Type | Limited Company (ltd.) |
| Legal Entity State | KOREA, REPUBLIC OF |
Documents
 Drawing | IMAGE/JPEG | 2019-07-17 |
 TEAS RF New Application | APPLICATION/XML,IMAGE/JPEG | 2019-07-17 |
| Suspension Letter | XML | 2019-10-10 |
| XSearch Search Summary | XML | 2019-10-10 |
| TEAS Response to Suspension Inquiry | MULTI | 2019-12-19 |
| Amendment and Mail Process Complete | MULTI | 2020-01-14 |
| Amendment to Delete or Correct Basis | MULTI | 2020-01-14 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-01-15 |
| Notice of Publication | XML | 2020-01-29 |
| Notification Of Notice of Publication | XML | 2020-01-29 |
| OG Publication Confirmation | APPLICATION/XML | 2020-02-18 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue; Ophthalmic preparations; Ocular pharmaceuticals
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue; Ophthalmic preparations; Ocular pharmaceuticals |
| GS0051 | Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue; Ophthalmic preparations; Ocular pharmaceuticals |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| PUBLISHED FOR OPPOSITION | 2020-02-18 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-02-18 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-01-29 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-01-14 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-01-13 | 66213 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-01-13 | 66213 |
| ASSIGNED TO LIE | 2020-01-13 | 66213 |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2019-12-19 | |
| SUSPENSION LETTER WRITTEN | 2019-10-10 | 90340 |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-10-10 | 6332 |
| LETTER OF SUSPENSION E-MAILED | 2019-10-10 | 6332 |
| ASSIGNED TO EXAMINER | 2019-10-03 | 90340 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-07-25 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-07-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 